Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C3H7O6P.2K |
| Molecular Weight | 248.2544 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[K+].[K+].OCC(CO)OP([O-])([O-])=O
InChI
InChIKey=KOJMAGAPHTUHAC-UHFFFAOYSA-L
InChI=1S/C3H9O6P.2K/c4-1-3(2-5)9-10(6,7)8;;/h3-5H,1-2H2,(H2,6,7,8);;/q;2*+1/p-2
| Molecular Formula | C3H7O6P |
| Molecular Weight | 170.0578 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | K |
| Molecular Weight | 39.0983 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.thegoodscentscompany.com/data/rw1610691.html | http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=multi_vitmin_suppl | https://www.google.ch/patents/US20090169685 | https://www.accessdata.fda.gov/scripts/fcn/fcndetailnavigation.cfm?rpt=eafuslisting&id=1747 | http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015774.pdfhttps://www.exercise.com/supplements/potassium-glycerophosphate
Sources: http://www.thegoodscentscompany.com/data/rw1610691.html | http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=multi_vitmin_suppl | https://www.google.ch/patents/US20090169685 | https://www.accessdata.fda.gov/scripts/fcn/fcndetailnavigation.cfm?rpt=eafuslisting&id=1747 | http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015774.pdfhttps://www.exercise.com/supplements/potassium-glycerophosphate
Potassium Glycerophosphate is a source of potassium. It is used in the treatment of nutritional deficiencies. Potassium supplements can be an important part of the recovery from or prevention of many different ailments and diseases. The most common of these include helping lower blood pressure and serving as a stroke preventative. Potassium can also be used to lower levels of calcium, to help with certain diseases including Alzheimer’s and Meniere’s. It may also help with some more common issues such as a common allergy, migraines, heavy acne, alcohol abuse, dizziness and confusion, extreme fatigue, recurring constipation, insomnia, anger and aggression, irregular heartbeat and stress. Potassium can either be taken as a supplement by mouth or it can be given intravenously to certain patients who require a faster dosing of the mineral or cannot take it orally.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Minadex Approved UseAs a treatment for vitamin and mineral deficiency and as an appetite stimulant during and after illness Launch Date1995 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:12:18 GMT 2025
by
admin
on
Mon Mar 31 18:12:18 GMT 2025
|
| Record UNII |
31S538FVCY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
74493-87-1
Created by
admin on Mon Mar 31 18:12:18 GMT 2025 , Edited by admin on Mon Mar 31 18:12:18 GMT 2025
|
PRIMARY | |||
|
31S538FVCY
Created by
admin on Mon Mar 31 18:12:18 GMT 2025 , Edited by admin on Mon Mar 31 18:12:18 GMT 2025
|
PRIMARY | |||
|
DTXSID80225496
Created by
admin on Mon Mar 31 18:12:18 GMT 2025 , Edited by admin on Mon Mar 31 18:12:18 GMT 2025
|
PRIMARY | |||
|
71587271
Created by
admin on Mon Mar 31 18:12:18 GMT 2025 , Edited by admin on Mon Mar 31 18:12:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
SOLVATE->ANHYDROUS |